Kochlik, B.; Stuetz, W.; Pérès, K.; Féart, C.; Tegner, J.; Rodriguez-Mañas, L.; Grune, T.; Weber, D.
Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative. J. Clin. Med. 2019, 8, 1010.
https://doi.org/10.3390/jcm8071010
AMA Style
Kochlik B, Stuetz W, Pérès K, Féart C, Tegner J, Rodriguez-Mañas L, Grune T, Weber D.
Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative. Journal of Clinical Medicine. 2019; 8(7):1010.
https://doi.org/10.3390/jcm8071010
Chicago/Turabian Style
Kochlik, Bastian, Wolfgang Stuetz, Karine Pérès, Catherine Féart, Jesper Tegner, Leocadio Rodriguez-Mañas, Tilman Grune, and Daniela Weber.
2019. "Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative" Journal of Clinical Medicine 8, no. 7: 1010.
https://doi.org/10.3390/jcm8071010
APA Style
Kochlik, B., Stuetz, W., Pérès, K., Féart, C., Tegner, J., Rodriguez-Mañas, L., Grune, T., & Weber, D.
(2019). Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative. Journal of Clinical Medicine, 8(7), 1010.
https://doi.org/10.3390/jcm8071010